-
公开(公告)号:US11964008B2
公开(公告)日:2024-04-23
申请号:US17931887
申请日:2022-09-13
Applicant: TAKEDA VACCINES, INC.
Inventor: Jill A. Livengood , Holli Giebler , Hansi Dean , Tatsuki Satou , Raman Rao , Jackie Marks , Mark Lyons , Asae Shintani , James Gifford , Sushma Kommareddy
CPC classification number: A61K39/12 , A61K9/0019 , A61K39/39 , A61P31/14 , C12N7/00 , A61K2039/5252 , A61K2039/54 , A61K2039/545 , A61K2039/55505 , C12N2770/24034 , C12N2770/24071 , C12N2770/24134 , C12N2770/24151 , C12N2770/24163 , C12N2770/24164
Abstract: The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation.
-
公开(公告)号:US12109260B2
公开(公告)日:2024-10-08
申请号:US18336439
申请日:2023-06-16
Applicant: TAKEDA VACCINES, INC.
Inventor: Jill A Livengood , Hansi Dean , Htay Htay Han , Raman Rao , Jackie Marks , Gary Dubin , Laurence De Moerlooze , Hetal Patel , Sushma Kommareddy
CPC classification number: A61K39/12 , A61K9/0019 , A61K39/39 , A61P31/14 , C12N7/00 , A61K2039/5252 , A61K2039/54 , A61K2039/545 , A61K2039/55505 , C12N2770/24034 , C12N2770/24071 , C12N2770/24134 , C12N2770/24151 , C12N2770/24163 , C12N2770/24164
Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
-
3.
公开(公告)号:US20230145065A1
公开(公告)日:2023-05-11
申请号:US17931887
申请日:2022-09-13
Applicant: TAKEDA VACCINES, INC.
Inventor: Jill A. LIVENGOOD , Holli Giebler , Hansi Dean , Tatsuki Satou , Raman Rao , Jackie Marks , Mark Lyons , Asae Shintani , James Gifford , Sushma Kommareddy
CPC classification number: A61K39/12 , A61P31/14 , C12N7/00 , A61K9/0019 , A61K39/39 , A61K2039/5252
Abstract: The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation.
-
公开(公告)号:US11975062B2
公开(公告)日:2024-05-07
申请号:US16768499
申请日:2018-11-30
Applicant: Takeda Vaccines, Inc.
Inventor: Jill A. Livengood , Hansi Dean , Htay Htay Han , Raman Rao , Jackie Marks , Gary Dubin , Laurence De Moerlooze , Hetal Patel , Asae Shintani , Holli Giebler , James Gifford , Mark Lyons , Sushma Kommareddy , Tatsuki Satou
CPC classification number: A61K39/12 , A61P31/14 , C12N7/00 , C12Q1/22 , A61K2039/5252 , A61K2039/545 , C12N2770/24134 , C12N2770/24151 , C12N2770/24163 , G01N30/74
Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
-
5.
公开(公告)号:US20240325518A1
公开(公告)日:2024-10-03
申请号:US18639558
申请日:2024-04-18
Applicant: Takeda Vaccines, Inc.
Inventor: Jill A. LIVENGOOD , Holli GIEBLER , Hansi DEAN , Tatsuki SATOU , Raman RAO , Jackie MARKS , Mark LYONS , Asae SHINTANI , James GIFFORD , Sushma Kommareddy
CPC classification number: A61K39/12 , A61K9/0019 , A61K39/39 , A61P31/14 , C12N7/00 , A61K2039/5252 , A61K2039/54 , A61K2039/545 , A61K2039/55505 , C12N2770/24034 , C12N2770/24071 , C12N2770/24134 , C12N2770/24151 , C12N2770/24163 , C12N2770/24164
Abstract: The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation.
-
公开(公告)号:US11730802B2
公开(公告)日:2023-08-22
申请号:US16761329
申请日:2018-11-05
Applicant: TAKEDA VACCINES, INC.
Inventor: Jill A Livengood , Hansi Dean , Htay Htay Han , Raman Rao , Jackie Marks , Gary Dubin , Laurence De Moerlooze , Hetal Patel , Sushma Kommareddy
CPC classification number: A61K39/12 , A61K9/0019 , A61K39/39 , A61P31/14 , C12N7/00 , A61K2039/5252 , A61K2039/54 , A61K2039/545 , A61K2039/55505 , C12N2770/24034 , C12N2770/24071 , C12N2770/24134 , C12N2770/24151 , C12N2770/24163 , C12N2770/24164
Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
-
-
-
-
-